Cytotherapy logo Informa Healthcare logo

Publisher: Informa Healthcare

More about this publication?
Related content
Volume 11, Number 3, May 2009

< previous issue | all issues | next issue >

Articles

The role of hypoxia-inducible factor in osteogenesis and chondrogenesis
pp. 261-267(7)
Authors: Sun, Xiaotang; Wei, Yiyong

Similar proteomic profiles of human mesenchymal stromal cells from different donors
pp. 268-277(10)
Authors: Lazzarotto-Silva, Carolina; Binato, Renata; Rocher, Barbara Du; Costa, Julia Assuncao Costa; Pizzatti, Luciana; Bouzas, Luis Fernando; Abdelhay, Eliana

Results of a pilot study on the use of third-party donor mesenchymal stromal cells in cord blood transplantation in adults
pp. 278-288(11)
Authors: Gonzalo-Daganzo, Rosa; Regidor, Carmen; Martin-Donaire, Trinidad; Rico, Miguel Angel; Bautista, Guiomar; Krsnik, Isabel; Fores, Rafael; Ojeda, Emilio; Sanjuan, Isabel; Garcia-Marco, Jose; Navarro, Belen; Gil, Santiago; Sanchez, Rocio; Panadero, Nuria; Gutierrez, Yolanda; Garcia-Berciano, Miguel; Perez, Nuria; Millan, Isabel; Cabrera, Rafael; Fernandez, Manuel

Therapeutic potential of mesenchymal stromal cells in a mouse breast cancer metastasis model
pp. 289-298(10)
Authors: Sun, Bo; Roh, Kyoung-Hwan; Park, Jeong-Ran; Lee, Sae-Rom; Park, Sang-Bum; Jung, Ji-Won; Kang, Soo-Kyung; Lee, Yong-Soon; Kang, Kyung-Sun

Injectable soft-tissue augmentation by tissue engineering and regenerative medicine with human mesenchymal stromal cells, platelet-rich plasma and hyaluronic acid scaffolds
pp. 307-316(10)
Authors: Okabe, Kazuto; Yamada, Yoichi; Ito, Kenji; Kohgo, Tomoyuki; Yoshimi, Ryoko; Ueda, Minoru

Research on promoting periodontal regeneration with human basic fibroblast growth factor-modified bone marrow mesenchymal stromal cell gene therapy
pp. 317-325(9)
Authors: Tan, Zhen; Zhao, Qing; Gong, Ping; Wu, Yang; Wei, Na; Yuan, Quan; Wang, Chuan; liao, Dapeng; Tang, Hua

Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse origin
pp. 330-340(11)
Authors: Kubikova, I.; Konecna, H.; Sedo, O.; Zdrahal, Z.; Rehulka, P.; Hribkova, H.; Rehulkova, H.; Hampl, A.; Chmelik, J.; Dvorak, P.

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
pp. 341-355(15)
Authors: Berg, Maria; Lundqvist, Andreas; McCoy, Philip; Samsel, Leigh; Fan, Yong; Tawab, Abdul; Childs, Richard

Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen
pp. 356-361(6)
Authors: Delgado, J.; Marco, A.; Moreno, E.; Pinana, JL; Valcarcel, D.; Martino, R.; Briones, J.; Sureda, A.; Brunet, S.; Sierra, J.

Evoked potential studies can only be interpreted as a neurophysiologic measure if applied accurately
pp. 372-373(2)
Authors: Bek, Semai; Eroglu, Erdal; Odabasi, Zeki

Response to Letter to the Editor
pp. 374-374(1)
Authors: Deda, Haluk; Kayahan, Kaan

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page